The content discusses the importance of a report from the Health IT Standards Committee and its implications for health IT and health reform. The report focuses on the evaluation of different technical standards for health information exchange. There is debate around the standards, with some favoring “look-up and retrieve” capabilities and others favoring “send/push” capabilities. The content also mentions the need for analysis of health outcomes from different exchange approaches.
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused
